5-Amino-1MQ Dosage Subcutaneous: What Research Protocols Use

There is no established human dose of 5-amino-1MQ, and the compound is not FDA-approved for injection or any other human use. Published rodent studies used roughly 5 mg per kilogram of body weight per day, while research-supply vendors and self-experimenters commonly cite subcutaneous amounts between 2.5 mg and 5 mg per day for an adult-sized subject. Every subcutaneous figure is an extrapolation from animal data, not a clinical recommendation.

What 5-Amino-1MQ Is and Why the Route Matters

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small synthetic molecule studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. NNMT activity has been linked to fat-cell metabolism in laboratory models, which is why the compound shows up in metabolic research rather than in clinical medicine.

Subcutaneous administration means injecting into the fatty layer just beneath the skin, where absorption is slower and steadier than an intravenous push. Injecting also bypasses the digestive tract, which matters because 5-amino-1MQ is a charged quaternary ammonium compound that absorbs poorly through the gut.

5-Amino-1MQ is a laboratory research compound, not a medication, so no dosing schedule has been validated in humans.

Most people searching for a 5-amino-1mq subcutaneous injection dosage are looking for a weight-based starting point that simply does not exist in peer-reviewed human literature.

Reported Dosage Ranges in Research and Vendor Guidance

Animal work is the only source of quantitative dosing data. Rodent studies typically delivered about 5 mg/kg per day, often by oral gavage or in feed, and reported metabolic changes in the treated animals.

Animal milligrams per kilogram do not translate directly to humans because of differences in metabolism, body composition, and clearance. Allometric scaling formulas exist, but none have been validated for this compound.

Vendor pages that discuss 5-amino-1mq dosage per day generally land on a once-daily subcutaneous injection, with a minority of protocols splitting the total into two smaller shots. The table below shows what common weight-based estimates look like in practice; it is a math reference, not a recommendation.

Body weight	50 mcg/kg/day	100 mcg/kg/day	150 mcg/kg/day
50 kg (110 lb)	2.5 mg	5 mg	7.5 mg
70 kg (154 lb)	3.5 mg	7 mg	10.5 mg
85 kg (187 lb)	4.25 mg	8.5 mg	12.75 mg
100 kg (220 lb)	5 mg	10 mg	15 mg

There is no peer-reviewed human dose-response study for 5-amino-1MQ, so every weight-based number above is an estimate rather than a target.

How to Calculate a Dose From a 10 mg Vial

Before drawing anything, review 5-amino-1mq reconstitution and dosage basics: powder mass, diluent volume, and final concentration. A 5-amino-1mq dosage calculator only works when you already know the concentration in the vial after mixing.

1. Add bacteriostatic water to the lyophilized powder and swirl gently; do not shake, because foaming can denature the compound.
2. Divide the powder mass by the volume of water added to get concentration in mg/mL.
3. Divide your target dose in mg by that concentration to get the volume in mL.
4. Convert mL to units on a U-100 insulin syringe, where 1 mL equals 100 units.

Example: 2 mL of water added to a 10 mg vial yields 5 mg/mL. A 5 mg target dose is 1 mL, which equals 100 units on a U-100 syringe.

The single most common question online is how to convert a 5-amino-1mq 10mg injection dosage, because 10 mg vials dominate the research market. Always double-check your math with a second person or a written formula before injecting.

Subcutaneous vs Oral: Does the Route Change the Dose?

Route changes absorption, and absorption changes the amount that reaches circulation. Because a 5-amino-1mq oral vs injection dosage comparison rarely produces matching numbers, the two routes should not be treated as interchangeable.

Factor	Oral (capsule or liquid)	Subcutaneous injection
Absorption	Variable and likely low for a charged molecule	Slower, steadier release from fat tissue
Commonly cited research range	Often listed higher to offset poor uptake	Roughly 2.5–5 mg per day in vendor guidance
First-pass liver metabolism	Yes	Largely bypassed
Sterility requirements	Low	High; requires clean technique and sterile supplies
Human data	None	None

Researchers comparing metabolic compounds also look at slu-pp-332 vs 5-amino-1mq, since both appear in preclinical work on fat-cell energy expenditure.

Timing, Frequency, and Injection Technique

Plasma levels of 5-amino-1MQ fall quickly in animal models, which is why some protocols split the daily amount into two injections. Others stay with one shot per day for simplicity.

Basic subcutaneous technique reduces the risk of infection and irritation:

• Wipe the vial stopper and injection site with an alcohol swab and let both dry.
• Use a fresh needle every time and never reuse a syringe.
• Pinch a fold of skin, insert at roughly 45 degrees, and rotate sites to avoid lumps.
• Store lyophilized powder cold and dry, and keep the reconstituted vial refrigerated.

Nothing about subcutaneous injection makes an unapproved research chemical safe, and sterile technique only reduces some of the risk.

Safety, Legal Status, and When to Ask a Professional

5-Amino-1MQ is sold as a research chemical and is labeled "not for human use." That label is a legal statement, not a marketing quirk.

NNMT is involved in many tissues, so inhibiting it broadly could affect pathways beyond fat metabolism. No long-term human safety data, interaction data, or toxicity data exists for this compound.

Anyone considering it should talk with a physician or pharmacist who can review medications, contraindications, and monitoring. Self-experimentation with an unapproved injectable carries real risks, including infection, allergic reaction, and unknown organ effects.

Practical Takeaways

• No human dose of 5-amino-1MQ has been established in clinical trials.
• Rodent research used about 5 mg/kg per day, and vendor guidance usually cites 2.5–5 mg per day subcutaneously.
• Dose math depends entirely on reconstitution concentration, so calculate in mg/mL first and convert to syringe units second.
• Subcutaneous injection bypasses digestion but does not make the compound approved, tested, or safe.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical 5-amino-1MQ subcutaneous dose?

No human dose has been established, because 5-amino-1MQ has never completed clinical trials in people. Rodent studies used roughly 5 mg/kg per day, and research-supply vendors commonly cite 2.5 mg to 5 mg per day subcutaneously for an adult-sized subject. Those numbers are extrapolations, not medical guidance.

How do I reconstitute 5-amino-1MQ for subcutaneous injection?

Add bacteriostatic water to the lyophilized powder and swirl gently instead of shaking. A common example is 2 mL of water added to a 10 mg vial, which produces a 5 mg/mL solution, so a 5 mg dose equals 1 mL or 100 units on a U-100 insulin syringe. Keep the reconstituted vial refrigerated and follow sterile technique.

Is 5-amino-1MQ FDA-approved for human use?

No. 5-Amino-1MQ is sold as a research chemical and carries a "not for human use" label, and it has not been reviewed by the FDA for safety or efficacy. Human data on dosing, side effects, and long-term risk does not exist. Anyone considering it should speak with a licensed healthcare professional first.